Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanae Toyonaga

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Molecular Pharmaceutics|September 26, 2025
Defective Host Immunity in a Mouse Hindlimb Ischemia Model Attenuates the Blood Flow Recovery Promoted by an mRNA/LNP FormulationHanae Toyonaga, Lei Cheng, Hirotsugu Tanaka
Biomedicines|September 27, 2025
Th2 Suppression Through Antigen Liver Expression Using mRNA-LNP TechnologyKazunori Arai, Hanae Toyonaga, Lei Cheng, et al.
Molecular Therapy. Nucleic Acids|July 4, 2025
mRNA-based <i>in vivo</i> induction of ETV2 to restore blood flow in a preclinical mouse hindlimb ischemia modelHanae Toyonaga, Kazunori Arai, Mengdi Zhang, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Molecular Pharmaceutics|September 26, 2025
Defective Host Immunity in a Mouse Hindlimb Ischemia Model Attenuates the Blood Flow Recovery Promoted by an mRNA/LNP FormulationHanae Toyonaga, Lei Cheng, Hirotsugu Tanaka
Biomedicines|September 27, 2025
Th2 Suppression Through Antigen Liver Expression Using mRNA-LNP TechnologyKazunori Arai, Hanae Toyonaga, Lei Cheng, et al.
Molecular Therapy. Nucleic Acids|July 4, 2025
mRNA-based <i>in vivo</i> induction of ETV2 to restore blood flow in a preclinical mouse hindlimb ischemia modelHanae Toyonaga, Kazunori Arai, Mengdi Zhang, et al.
Pageof 1